InvestSMART

Microba Life Sciences Limited (ASX: MAP) - Announcements

- Current share price for MAP : $0.037

ASX company news and announcements for Microba Life Sciences Limited (MAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Microba Life Sciences Limited (MAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Microba Life Sciences Limited (MAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Microba Life Sciences Limited (MAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$27 Letter to Shareholders, Notice of AGM & Proxy Form 25 Oct 2022 12:56PM $0.160 $0.037 fallen by 76.88%
$27 Change in substantial holding 25 Oct 2022 10:37AM $0.150 $0.037 fallen by 75.33%
$27 Microba, SYNLAB Extend & Expand Distribution 20 Oct 2022 9:21AM $0.155 $0.037 fallen by 76.13%
$27 Ceasing to be a substantial holder 19 Oct 2022 3:37PM $0.150 $0.037 fallen by 75.33%
$27 Investor Presentation October 2022 17 Oct 2022 9:17AM $0.140 $0.037 fallen by 73.57%
$27 Date of AGM and Closing Date for Director Nominations 7 Oct 2022 8:57AM $0.170 $0.037 fallen by 78.24%
$27 Release of Restricted Securities 27 Sep 2022 9:04AM $0.195 $0.037 fallen by 81.03%
$27 Initial Director's Interest Notice - Jacqueline Fernley 8 Sep 2022 9:18AM $0.210 $0.037 fallen by 82.38%
$27 Director Appointment - Jacqueline Fernley 8 Sep 2022 9:12AM $0.210 $0.037 fallen by 82.38%
$27 Becoming a substantial holder - Tiga Trading Pty Ltd 6 Sep 2022 5:36PM $0.210 $0.037 fallen by 82.38%
$27 Becoming a substantial holder from TEK 6 Sep 2022 5:36PM $0.210 $0.037 fallen by 82.38%
$27 Change in substantial holding 5 Sep 2022 10:41AM $0.210 $0.037 fallen by 82.38%
$27 Therapeutic Program Advancement 31 Aug 2022 9:21AM $0.210 $0.037 fallen by 82.38%
$27 Investor Presentation - FY22 Update Annual Results 30 Aug 2022 9:16AM $0.210 $0.037 fallen by 82.38%
$27 Appendix 4G 25 Aug 2022 10:16AM $0.200 $0.037 fallen by 81.50%
$27 Corporate Governance Statement 25 Aug 2022 10:14AM $0.200 $0.037 fallen by 81.50%
$27 Appendix 4E & Annual Report 25 Aug 2022 10:14AM $0.200 $0.037 fallen by 81.50%
$27 Change in substantial holding 23 Aug 2022 6:05PM $0.210 $0.037 fallen by 82.38%
$27 Change in substantial holding 19 Aug 2022 3:18PM $0.215 $0.037 fallen by 82.79%
$27 Microba receives two AusIndustry Advanced Overseas Findings 22 Jul 2022 3:56PM $0.295 $0.037 fallen by 87.46%
$27 Investor Update - Q4 FY22 Results 20 Jul 2022 9:25AM $0.240 $0.037 fallen by 84.58%
$27 Q4 FY22 Quarterly Activities Report & Appendix 4C 20 Jul 2022 9:05AM $0.240 $0.037 fallen by 84.58%
$27 Details of Q4 FY22 Investor Webinar 19 Jul 2022 9:05AM $0.220 $0.037 fallen by 83.18%
$27 Global Leader IFF and Microba Reach First Milestone 4 Jul 2022 9:07AM $0.200 $0.037 fallen by 81.50%
$27 Genova Diagnostics Partnership Commences in the US 30 Jun 2022 9:12AM $0.225 $0.037 fallen by 83.56%

301 - 325 of 714 results

Page 13 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.